Medicare’s Hidden Fix for High Drug Costs
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print
Blog Post
Chart of the Day: Impact of Participation in Bundled Payments for Physician Groups and Hospitals
Examining How Financial Savings Differ Across Participant Types
Print:
Bundled payments are a key strategy used by payers to reduce costs around episodes of care. However, little is known about how well physician group practices vs. hospitals perform when participating in these alternative payment models. Medicare’s Bundled Payments for Care Improvement (BPCI) program, which covers the costs of medical and surgical episodes from hospital admission for up to 90 days of post-acute care, offers an opportunity to answer this question.
In a new JAMA Health Forum study, LDI Adjunct Senior Fellow Joshua Liao, Senior Fellow Amol Navathe, and colleagues examine cost outcomes in physician groups and hospitals participating in the BPCI program.
After assessing claims data from over 1.2 million Medicare beneficiaries, they found that spending for surgical episodes decreased similarly for hospitals and physician groups. However, for medical episodes, only hospitals achieved significant reductions.
As policymakers and payers continue to design and evaluate bundled payment models, they should consider how the performance of participant types compares to others for various types of care. In this study, hospitals seemed better positioned to achieve savings in medical episodes while both were successful around surgical episodes.
The study, “Performance of Physician Groups and Hospitals Participating in Bundled Payments Among Medicare Beneficiaries,” was published on December 9, 2022, in JAMA Health Forum. Authors include Joshua Liao, Qian Huang, Erkuan Wang, Kristin Linn, Torrey Shirk, Jingsan Zhu, Deborah Cousins, and Amol Navathe.
Author
Kaday Kamara
Policy Coordinator
More on Health Care Access & Coverage
Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
How One Study Helped Save Free Preventive Care in a Supreme Court Showdown
A 2024 Study Showing How Even Small Copays Reduce PrEP Use Fueled Media, Legal, and Advocacy Efforts As Courts Weighed a Case Threatening No-Cost Preventive Care for Millions
Insurers’ Utilization Management Tools Vary Widely on Anti-Nausea Drugs for Cancer
Chart of the Day: LDI Researchers Report Major Coverage Differences Across ACA and Medicaid Plans, Affecting Access to Drugs That Treat Chemo-Related Nausea
Why You May Have Fewer Health Insurance Choices Than Your Neighbor
Insurers Avoid Counties With Small Populations and Poor Health but a New LDI Study Finds Limited Evidence of Anticompetitive Behavior
Acupuncture Could Fix America’s Chronic Pain Crisis–So Why Can’t Patients Get It?
A Proven, Low-Risk Treatment Is Backed by Major Studies and Patient Demand, Yet Medicare and Insurers Still Make It Hard To Use